🔗 Share this article Social Media Influencers Fueling Unofficial Trade for Unapproved Slimming Drug A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations. Investigational Treatment Gaining Popularity Via Social Media The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to message these profiles directly for source information, while also receiving promotional offers. Thriving Commerce on Social Networks Additionally, a robust market exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the substance there before redirecting buyers to other platforms for purchases. Understanding The Experimental Drug Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic. Medical Experts Express Concerns However, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could result in users administering substances of unknown origin. Several professionals said the demand for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro. Legal Position and Enforcement Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012. Several content creators try to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment. Platform Reaction and Content Removal According to the social media company, the platform has taken down violative content and banned related keywords and search suggestions. The company stated it was dedicated to maintaining the platform safe and allocating resources in strengthening compliance measures. Online Marketplace Activities Investigations also discovered communities with up to nine thousand members marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of users, filled with photos of weight loss, positive reviews and detailed instructions for mixing or injecting at home. Within minutes of joining one community, a seller posted contact information, where the majority of transactions occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage. Item Details and Costs Inside these communities, messages display dark colored packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”. Platform Oversight and Security Measures A spokesperson for Telegram stated it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Medical Expert Warnings “Individuals are administering materials they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U. A medical professional of an online medical service connected the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained. Her team has previously seen individuals injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.” Manufacturer Statement A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to potentially serious health risks”.